text:
PostgradForum
abababa
Overview of abababa
Signup date: 18 Feb 2015 at 4:39pm
Last login: 26 Nov 2020 at 4:20pm
Considering leaving after 3 months
abababa 51 posts
You are right to be looking at exit strategies, sadly. You've done the right thing by insisting on time to focus on study, allowing these problems to be identified; but there's no quick or surefire solution.
Having supervised a PhD with a small company before, I've seen these issues and it put me off working with SMEs towards the 'very small' end of the scale, funding a PhD.
On the one hand, yes they do pay the fees/stipend. But this is also a cheap, tax/NI free, talented member of staff if they abuse the system by giving that person a load of unrelated work. They may well have entered into it with the best of intentions, but with 10 people they don't have the capacity to reliably guarantee you'll not get repeatedly drafted in to solve problems elsewhere. Covid has probably exacerbated this, as the shifting financial situation of the company will also be a factor in whether something behind schedule is well-managed or an all-hands-on-deck panic.
I'm sure your supervisor does have a good relationship with them if he's enabling them to abuse the system, as it's a cosy win-win for the supervisor (who gets research funding on the CV), and the company (who get a cheap member of staff), whilst the student is the one that loses out, with two full-time job equivalents. I don't know if it's the case here, but as with any supervisor you'd probably want to know how many of their students have successfully completed or dropped out before, and if there were any with the same company.
With the company hemorrhaging managers this is also a worrying potential sign they either can't retain staff, or have a politic-y environment, or are flat out running low on cash and offering people the opportunity to resign, as is the fact the relationship with your industry sponsor is already starting to grate.
I don't want to be all doom and gloom though - it is worth reading the studentship agreement carefully, before making any decisions. If the company cuts the funding at some point in the future, what's the implication for you? Will the University step-in to cover the shortfall (unlikely but possible in the terms), or will you be left self-funding the remainder? Will that be affordable? You want to identify a Plan B so if you do need to dig your heels in and ask for better terms it can be on the basis of 'or I'll accept this alternate offer'. A strategy to try is setting immediate actions that you have control over - e.g. 'I will only respond to emails for company work on Fridays'. If you do choose to stick in there, you want to be agreeing tangible things and concrete tasks at meetings, not what an immeasurable % of your time will be spent doing.
Advice for project management
You're in a rare and fortunate but also challenging position, if you've not managed people before.
It is, in general, always better to spend budget in academia if you have it, otherwise it usually gets taken away.
One tip is to talk to the individual (or potential candidates), and try to identify their own long-term goals. If they want to do their own PhD, experience helping you analyse data or literature is something that they'll be more keen to do. If they want to go into industry, helping with programming aspects might be more useful to them. What's relevant will depend where you're up to in the PhD, but any boilerplate coding or statistical analysis etc. is fair game.
I would try to balance giving them tedious things they need to do, with interesting things they want to do. Bear in mind if it's just translation you need, you could pay a professional translator and probably get a better result for less cost. If they're intellectually-minded and/or ambitious, you may find they don't perform well at mundane, repetitive things; on the one hand, that doesn't mean you can't ever give them a mundane, repetitive task (that's why you pay them), but is also means you probably won't get the most out of them (and potentially a resignation) if that's all they do.
If you're stuck identifying interesting things they could do, ask them for their input (not doing this is a common management error). If you're interviewing, ask this to candidates. You may not be able to give them an accredited graduate project, but that doesn't mean you can't jointly devise something useful to you, and useful to them, and an employee will be more enthusiastic about undertaking a jointly devised task.
As a final note, the other thing to balance is giving them a task that's useful but not essential for your PhD. With any graduate RA role, you need a Plan B for anything mission-critical, since they don't exactly have a contract they're going to worry too much about quitting from, and limited experience/expertise.
My supervisor said this is correct - is it?
Be wary of asking on internet forums for a correct statistical analysis.
The root here, is that you give the impression you don't understand your own stats, and are attempting to 'blame' the supervisor for okaying them if they're wrong. This will not help you get a PhD.
To correctly infer if the numbers are entirely correct, you'd need the raw data and method. It is your job as a PhD candidate to understand this - it is completely reasonable if you consult a statistician - but not an internet forum. It will not hold up in viva if you say 'PhD forums said it was right' or 'supervisor said it was right' - you need to understand and answer this question yourself.
Should I do a PhD?
I'm in the relatively unique position of knowing a colleague who worked for the church and made the leap to a PhD.
For them, the original motivation was that it would enable them to teach at a higher level. This evolved over the course of the PhD, to the extent they're less interested in teaching now and work full-time as a researcher.
If you want to teach at University-level it is basically a pre-requisite; otherwise you're stuck as a TA for your entire career.
I wouldn't factor much the fact you're daunted by it; it will be hard, but it's actually a good sign if you realise this early on, and it probably won't be as hard as you think - but the only time you'll realise this is after completing it. A PhD will be very research-focused and whilst it serves as a passport to higher-level teaching positions it will take you away from teaching in the short term rather than towards it.
It is also my experience that the dedication and empathy a church role takes to support people spiritually and emotionally - however much you may describe the pressure as 'not enormous' - is something that will serve you extremely well when it comes to the hard work, rigour, and honesty involved in a PhD.
You sound well-suited; the only real consideration is the financial one. If you can come up with a way to make ends meet, I'd be very optimistic you'd succeed. If you self-fund, do 'shop-around', and be unafraid to commute, as it's a buyers market and you should be wary of accepting the first self-funded offer.
Lack of teaching experience
Speaking as an academic who's been on many panels, it's not really an issue in terms of 'job after PhD'. It will just be assumed you can teach it and you'll be appointed on the basis of REF-ability and potential to bring in funding. Quality of teaching is usually based on internal NSS proxies, which are as much to do with how students like you, as it is the quality of your content.
This isn't how it should be, but it's how it is. The problem I've seen more recently, is Unis care about on-time completions to the level they won't let PhDs engage in teaching, because (in their blinkered view) it reduces the probability of a 'timely' completion. Obviously, teaching and research go hand-in-hand in academia, and it's a false assumption, but since Unis are run by managers, it's a logical consequence.
It's also understandable these things are re-offered, because academics are human and will invariably want to avoid screwing over the TA that worked really hard on x the last year, to appoint new person y. Objective checks and measures should be used, but I'd think anyone would realise that what you want to look for are opportunties when people leave, rather than to kick a TA out of post on the promise of doing a better job (you may well be able to do it better, but it's a hard-minded manager that would enable and support this).
In short, you don't really have to worry about the lack of experience long-term, as a post-doc nobody really cares about your teaching portfolio, even if you're applying for a lectureship. But it will be a struggle to get one at your current place, since TAs are, for reasons above, generally 'stitched up'.
You could volunteer for free if you're particularly worried, but I'd be skeptical - likely the Uni would take your effort and there wouldn't be a commensurate return.
Need pre viva help to verify my stats
Most universities have a stats support programme. Make sure you check for this before help online.
I mean, if the covid vaccine etc. had been verified by a random online forum, then you'd be skeptical, right? Don't fall into the same trap with your own work. What you need is a professional statistician, and you probably won't find one posting here.
If you do resort to online, ask widely (multiple sources), and fundamentally use that to learn how to interpret your data - not as a get-out for not understanding it. Stats are so widely abused in research/politics/social media you need to understand them as a researcher. It's tedious, painful, but what you want to find is a good tutor at your Uni you can meet with to discuss and develop your knowledge, not a green light from here.
Undergrad unsure what to do
PS - if you go the self-funded route, it's still worth asking if the Uni could meet you in the middle, if you're on track for a good degree, and have a supervisor that's read your proposal and is interested in it. They will be unlikely to fully stipend you, but you may be able to get a fees waiver. It's usually considerably easier for an interested supervisor to use what little power they have to get the university to waive the fees in exchange for a really good potential of a timely PhD completion, rather than pay out a stipend.
It's very rare, in the UK, for a lecturer to have immediate access to PhD funding - i.e. be able to decide to take you on and make a funded studentship happen. What normally happens with any grants they secure, is they go out to jobs.ac.uk at the point the project they're related to starts. Candidates then apply in a normal job application scenario.
Unfortunately it's a bit of a false assumption that Universities fund PhDs (though most have small-scale, fought over schemes); the majority of funded PhDs come from UKRI or EU projects whose investigators are at the institution. This means there are comparatively few rolling 'open' calls for applications. If your Uni doesn't have an immediately apparent scheme, it's possible one doesn't exist.
It's very likely you'd need to move for a funded studentship given this, since you'd need to be applying for studentships funded by projects in your field, and the chances of there being one starting at the perfect time, at your institution, and you being the best candidate, are pretty slim.
Universities are, of course, open to self-funded applications. I think the reality might be you need to decide between mobility, or, if it's absolutely not an option and you're determined to do one, doing a self-funded full or part-time one at your local institution.
After a long journey - Post-OIA
I'll do my best here but please remember this is ultimately my opinion/limited experience:
(1) the student was given non clear advice;
This is subjective, a court wouldn't be expected to, or be capable of, judging what constitutes 'clear' advice to a PhD student.
(2) the university has acknowledged that provoked severe distress in the student due to lack of supervision and communication;
Bear in mind with a court the judge will likely have heard cases of bricks being thrown through windows, knives being pulled, or years of abuse; this doesn't make the stress of any individual experience less or more significant, but you do need to understand there's a (depressingly) high bar there around claiming for stress. If you're not claiming for stress, but a procedural failing, this doesn't help your argument.
(3) this stress is scientifically proven to affect the rational adjustment of a person, who becomes unable to estimate risk/reward ration and tends to ask and trust the opinion of an "expert" (aka Dean of Department);
It would be a court hearing, not a PhD viva. The way civil courts work they will want to be in and out in 15 minutes. It's also for this reason having multiple points isn't a strength; you want a single clear (ideally procedural) failing on the universities behalf, because they will find for the defendant if you don't provide one. Basically a judge will look (in about 10 minutes) for a) what was promised/contracted, b) the evidence this was not delivered. a) and b) need to be crystal-clear to win as if things get vague/complicated/compounded, it's in favour of the defendant.
(4) a deadline was coming;
Seems irrelevant.
(5) the observations reported timely by the same student (since 18 months) affected the viva; (6) in the entire university websites and regulations there is no written information on the possibility or procedures to postpone (so, actually, he didn't have really other options in that moment).
You may get them on this. Anything with regulations/procedures/breach of contract is where you would want to focus. If there's a lack of information that they're obliged to provide, or you were treated unequally due to them failing to provide you with information, you can win a case. Basically, the vast majority of cases won against universities are them failing to provide services as advertised or to-contract. As I mentioned in my previous post, though, they are aware of this and have stealthily and unethically been amending/carefully wording what they advertise and contract to protect themselves.
"I see. I got a fees-exempted scholarship for my Ph.D. (so I did it for free, but I did not have a full scholarship and had to pay my living expenses working part-time), so you think that I cannot appeal for my +14 months (when they could have been +2) if my supervisor actually did his job as reported in the university's regulations (which is technically my contract, right, through which I am entitled with some services)?
You can (though it would more accurately be a complaint over the time you did not receive supervision, and - more difficult to argue - the consequences. It's very hard to argue rationally beyond doubt that if the supervisor had done their job you'd have passed sooner. It's also hard to argue they forced you to submit if you signed the form.
The hard bit over supervision, would that legally this would be assessed 'as contracted'. Not answering for 5 weeks might seem unreasonable, but you will probably find the University *promises* you (contractually binds themselves to) a scandalously low amount of supervision. For many Unis, the contracted amount of supervision is something like 20-40 hours a year, including time to review your drafts. It usually does not specify how frequent this should be, and will almost inevitably have no clause they they will respond within x weeks.
It's pretty scandalous tbh as any competent supervisor is going to put in way more than 20 hours per year, but legal departments at universities have become savvy to litigious students, and this protects them against that, because all they'd have to show is that over the calendar year you had a few meetings and feedback on a draft. Applications for studentships are so competitive most people are happy to sign (or don't check) against these terms.
As others have said, you may well be best served cutting your losses and moving on. It's a risk if you spend money on litigation, since whilst I'd readily agree with you the Uni is not in the right morally or ethically, I can see their position arguable legally, and that's what would matter in court.
Can a different phd topic give you renewed enthusiasm
There is an element of 'graft' in any PhD, regardless of whether you pick the topic or not. Most successful PhDs are absolutely sick of their own thesis by the time they graduate. To research even the most interesting topic rigorously usually involves a degree of repetition, tedium, and attention-to-detail.
So, changing topic won't automatically be a magic solution, if the problem arose from the tedium and monotony of academic rigour. Especially if you don't want to go into academia I'd carefully consider the 'cut your losses' route, as employers outside of academia tend to attach little value to a PhD, and you'd be better off with 3 years industry experience than a PhD. This obviously depends on the field/area/what you want to do with your life, but if you're not interested in becoming an academic, I'd think carefully before spending both money and time training to become one.
I'm not sure if you're misinterpreting, since you appear to have passed w/ majors and been given 14 months to do them.
This doesn't mean you need to take 14 months, but you do need to address the corrections. You'd be perfectly entitled to refuse any work other than the corrections if you're not being paid to do it.
I don't think you're necessarily in a worse position here, as you survived the viva, and the alternative as I can see it is they'd advised you not to submit, and spend another 12 months working on it, in which case the ultimate time for you to complete the PhD would, in all likelihood, be longer.
If you have evidence you literally got nothing from your supervisor for 6 months, then you're also not in a bad place (still having passed). Most universities have a policy indicated the minimum contact time for a supervisor (this is typically low, but it's rarely silent-for-6-months-right-before-submission-is-ok low), so you could appeal for reimbursement of fees based on lack of supervision. It's important to note you can never appeal or complain for a better outcome, or 'free' PhD due to supervisor negligence, but you can absolutely appeal for reimbursement if you paid money for supervision at an agreed level (written into the paperwork) and didn't get it.
PhD help
It's definitely not impossible, and I disagree that the 2:1 at undergrad is a major barrier as well. Admittedly if you're trying to get into a world-leading group at a top uni, it's probably the case that the majority of applicants will have 1sts/distinctions/know the right people from Eton. But for the remaining 95% of opportunities, you would likely meet the requirements to get through the initial sift, and it will be more down to how you perform at interview. Most experienced academics have learnt (often the hard way) a student with top grades is not automatically the best PhD candidate - especially if they have top grades because they're really good at exam technique and working to short, clear, assessed objectives; both of which are almost irrelevant to a PhD.
If you come across as knowledgeable, passionate, and can explain away the grade (or just say you have an MSc, which is true, and should be grounded in the kinda-ridiculous-when-you-think-about-it fact that what you feel was an awful result was only 12% off a distinction), you will be in good stead.
It's probably worth noting you would substantially increase your chances if you're not constrained to looking in the UK.
You're also in the fortunate position of having a full-time job, so you can take the time to keep applying. If you do this, and accept the odds of success per application are going to sit around 5%, then you'll recognize it will take patience but is very unlikely to be a lost cause.
Btw it seems a really bad idea to do a 2nd self-funded masters in the hopes of getting a higher grade. That's based on some really risky assumptions (that you'll get one, and that it will make the difference). It's not just £3k you're gambling but a year of lost earnings while you study. I'd put the £3k on a roulette table and shoot for self-funding a PhD with the winnings before doing that...
Will low self-esteem hold me back?
The general progression for me over my academic career has been gaining the confidence not by my own gains in knowledge, but the realization that pretty much everyone in academia is 'normal' (including myself).
I would not say they're faking it, as this implies there's a 'genuine' academic majority who are the kind of geniuses I daresay the general public or undergraduates think of. I learned progressively that:
1) Most multi-million dollar research grants are not genius science concepts, but obvious incremental work, that most people could come up with in 15 minutes with a Wikipedia-level knowledge of the field. But only an academic would suffer writing it as 100 pages in a particular style.
2) Most professors know about 5 vaguely current papers well, plus the one their PhD student mentioned in the last meeting, and mention them in every meeting to sound well-read.
3) Most academics have developed an air of authority not from mastery of a field, but from the necessity of telling students at the back to be quiet on a daily basis.
4) A good academic is probably not an expert in their field in the sense of knowing that much about it, they're a good academic because they've repeatedly screwed up basic things like how to do an ANOVA or write a literature review, and learned from it.
PhD viva tomorrow can't get myself to do a thing
Read them carefully; then do them.
It's simple advice, but you're in a position now where it's (statistically) hard to *not* get a PhD.
Your examiners will be faced with the simple option - is this a PhD, or a fail. It takes a really harsh examiner to fail a PhD after minors. What you don't want to do, is give them the impression you don't care about the corrections, or haven't listened.
In general, you should always submit a secondary document explaining how you've addressed each correction you received, with a page reference to the thesis. This helps examiners massively, as they don't have to then trawl through the thesis trying to find if the correction was addressed. I'd wait until you get the list of corrections, tabulate them, then work through one-by-one, adding to the table how you addressed it.
If you find one you strongly disagree with, you could instead provide an academic argument in this table as to why, on reflection, you've not undertaken the correction, but this is one to be super-careful with, as the academic argument you provide needs to be pretty water-tight.
You can do additional corrections outside of this, but bear in mind what an examiner really cares about is a) did the candidate listen, and b) did they undertake the correction - and if not, why not. It will be - very likely - extremely painful for them if they fail you after a successful viva, so provided you show genuine effort listening to where they're coming from, and addressing the corrections, you will, almost undoubtedly, be Dr. wekkies very soon :)
Postgraduate Forum
Postgrad Forum Rules
Masters Funding
Masters Study Guide
Advertise Masters Courses
Latest PhDs
PhD Funding
PhD Study Guide
Advertise PhDs
Contact Us- Rules- Privacy
PostgraduateForum Is a trading name of FindAUniversity Ltd
FindAUniversity Ltd, 77 Sidney St, Sheffield, S1 4RG, UK. Tel +44 (0) 114 268 4940 Fax: +44 (0) 114 268 5766
Welcome to the world's leading Postgraduate Forum
An active and supportive community.
Support and advice from your peers.
Your postgraduate questions answered.
Use your experience to help others.
Sign Up to Postgraduate Forum
Enter your email address below to get started with your forum account
Enter your username below to login to your account
Please enter your username or email address to reset your password
An email has been sent to your email account along with instructions on how to reset your password. If you do not recieve your email, or have any futher problems accessing your account, then please contact our customer support.


* This Value Pack contains Books 3 and 4 of What Can We Play on Sunday?, a series of six books of piano duets (one piano, four hands), each book designed for busy pianists who require accessible arrangements.
* Book 3 contains selections for holidays and holy days that occur during May and June, including Ascension, Mother's Day, Pentecost, and Father's Day.
* Book 4 contains selections for holidays and holy days that occur during July and August.
* Each book also contains several general hymns.


Robin Lehner made 26 saves for his 5th shutout of the season and the Isles got an early goal from Jordan Eberle and a late goal by Brock Nelson as they defeated the Arizona Coyotes 2-0 before a sellout crowd of 13,917 at Nassau Coliseum.
The victor gives the Isles a sweep in the final set of back-to-backs this season; the Isles went 11-1-1 in the back-end games.
The win gives the Isles 95 points, which is the most through 76 games in the post-Cup era; It also keeps the Isles within one point of Washington (who defeated Philadelphia 3-1); idle Pittsburgh has 93 points and will visit Madison Square Garden on Monday. All three teams have six games to play.
The Isles' magic number to clinch a playoff spot is now 5; they could clinch a playoff spot on Tuesday (with a regulation win) in Columbus if the Blue Jackets lose to regulation to Vancouver Sunday night.
The Isles are 30-13-3 in their last 46 games; they are once again 19 games over NHL-500, matching the season-high… It's the 10th shutout of the season, tying the club record set in 1975-76…Both Isles goalies have five shutouts; they are the 10th team in NHL history to have two goals with at least five clean sheets…The Isles have surpassed last season's win and point total; including shootout winners they have scored 30 fewer goals and allowed 92 fewer goals than last year's first 76 games… The Isles have 50 points at home and 45 points on the road … The Isles went 0-1 on the power play and have scored just once in their last 37 attempts… The Isles have 23 wins at home and 21 wins on the road; it's only the 4th time in the post-Cup era that the Isles have won at least 21 games both at home and on the road (2001-02, 2014-15, 2015-16)… The Isles played the final 3:14 with a 2-goal lead after doing so over the final 2:34 on Saturday; there are the only times since March 5th (other than following empty-net goals) that the Isles have played with a multi-goal lead…Brock Nelson reached 50 points for the first time in his career…Jordan Eberle's goal was his 40th as an Islander; 11 of the 40 are game-winners. He is the only player in Islander history to score at least 11 GW Goals with as few as 40 career goals.
Magic Numbers:Montreal's overtime loss lowered the Isles' Magic Number to clinch a playoff spot is 5. While either Montreal or Columbus could still get to 100 points by winning all of their remaining games, they play each other on Thursday, so one team is guaranteed to finish with 99 or fewer.
It could go as low as 4 (with a Columbus regulation loss in Vancouver) on Sunday.
The Isles allowed one goal or fewer for the 26th time this season. That is a new franchise record; the Isles allowed one goal or fewer 25 times in 1975-76.
Robin Lehner has played 151 minutes in his last three appearances, allowing only two goals, including a shutout. He has stopped 65 of 67 shots in that span, for a 0.79 GAA and a 97.0 save percentage.
The Isles are 31-14-6 when Casey Cizikas, Matt Martin and Cal Clutterbuck all play and are 13-11-1 when one or more miss a game.
Casey Cizikas was EVEN and is now +22 on the season. Brock Nelson was +1 and is now +21 on the season. In the last 30 seasons, only five Islander forwards have finished +22 or higher.
The most road points that the Isles have earned in a full season is 53 in 1976-77 and 1980-81 (both were 80-game seasons).
The Isles are 12-5-2 in their last 19 road games and 15-6-2 in their last 23 road games.
Barry Trotz coached his 1,600th NHL game and 2,000th professional game.
Among active coaches, Trotz has coached the most games and is 2nd to Ken Hitchcock in wins. Trotz' NHL record is 806-593-60-141 in 1,600 games.
The Isles are 28-9-5 when scoring first and are 16-16-2 when allowing the opening goal (which includes a 1-0 shootout loss).
The Islanders are 44-25-7 overall; 23-12-4 at home (11-6-2 on Long Island and 12-6-2 in Brooklyn) and 21-13-3 on the road. All their remaining regular season home games are at the Nassau Coliseum.
Arizona is 36-33-7 overall; 18-15-4 at home and 18-18-3 on the road.
The Isles are 17-8-1 in Division games and 27-17-6 in games versus other divisions. The Isles are 27-15-5 against the East and 17-10-2 against the West.
Robin Lehner made 31 saves as he improves to 22-12-5 on the season and 5-0-0 in his career against Arizona.
Darcy Kuemper made 24 saves but falls to 24-19-7 on the season and 1-3-1 against the Islanders.
The Isles were 0-1 on the power play in 2:00 of PP time; Arizona was 0-1 on the power play in 2:00 of PP time.
The Isles are 23-2-2 when they score at least one power play goal and 21-23-5 when they do not. The Isles are 15-14-5 when they allow at least one power play goal and 29-11-2 when they do not.
The Isles are 35-2-2 when they score at least three goals (including shootout winners) and are 9-23-5 when they do not.
• The Isles are 27-24-5 when both teams are rested.
Isles record by ice-time leader: Ryan Pulock (21-13-5), Nick Leddy (14-9-2), Scott Mayfield (8-1-0), Johnny Boychuk (0-1-0), Adam Pelech (1-0-0), Mathew Barzal (0-1-0).
Isles 24, Arizona 24 (50%).
Casey Cizikas won 8 of 13 for the Isles; Brad Richardson won 10 of 13 for Arizona.
Face-offs by period: 1st period 9/20; 2nd period 7/11; 3rd period 8/17.
Face-offs by strength: Even strength: 21/44, Power play 1/2, Penalty kill 2/2.
Today was the final game of the final back-to-back of the season. The Isles went 8-4-1 in the front half and 11-1-1 in the back half.
The Isles are 36-21-7 in night games and 8-4-0 in matinees. The remaining games are all at night.
Anders Lee 194, Brock Nelson 171, Mathew Barzal 158. Four other Isles: Nick Leddy, Ryan Pulock, Josh Bailey and Leo Komarov have appeared in every game this season.
The teams sweep the season series 2 games to 0 (and 4 points to 0).
The Isles have won six straight home games from the Coyotes and are 9-0-1 at home vs. the Yotes since the then-Phoenix Coyotes defeated the Isles 3-2 on October 29, 2002.
Chris Bourque scored a goal and added two assists as the Sound Tigers stretched their home point streak to ten games (9-0-1-0) with a 4-1 win over Syracuse at Webster Bank Arena. Jeremy Smith stopped former Islander Cory Conacher on a penalty shot as he reached the 20-win mark for the 4th time in his career.
Bridgeport is 11-2-1-0 in their last 14 games, is 15-3-2-0 in their last 20 games and 39-20-6-2 on the season.
Bridgeport continues their eight-game homestand on Wednesday against division-leading Charlotte. The Sound Tigers' magic number to clinch a playoff spot is 7.
The Isles look to sweep the season series (and based on Sunday night's results possibly clinch a playoff spot) as they begin a 2-game road trip in Columbus against the Blue Jackets.
The Isles have won all three games between the teams, including the last two by shutouts. Since the Jackets scored the first two goals in the Coliseum re-opener, the Isles have outscored Columbus 8-0 and not allowed a Jacket goal in 151:27. Thomas Greiss has been in the Islander goal for all three victories.


text:
Ottawa's ByTowne Cinema Announces Closure
The 650-seat theatre will close December 31
Ottawa's ByTowne Cinema — a single-screen, 650-seat theatre beloved by locals for its international and independent film programming — has announced plans to close come the end of this year.
Operator Bruce White made the announcement today, citing difficulties posed by the coronavirus pandemic and resulting restrictions. He wrote that the ByTowne "has been losing money every day since the pandemic hit. Even when we've been allowed to be open, audiences are dramatically smaller."
White noted, "The ByTowne has a fantastic customer base, but many ByTowners just aren't coming these days. And I don't blame them: our staff have done an amazing job with COVID protocols that keep customers as safe as possible, but everyone's risk assessment is personal, and specific to their circumstances."
Additionally, White pointed to the decision being influenced by a shortage of films to screen. He explained, "Since the pandemic hit, distributors have also had to make some business decisions. They've sold some titles to streaming services, skipping the marketing expense of releasing them to only a few limited-seating cinemas. Other movies have been moved from fall and winter releases to, well, some unspecified point in a possibly rosier future."
White also shared that in August of 2019, he had been working on a succession plan for the cinema, as he is "at retirement age, and the cinema could use fresh ideas."
"It's still possible that someone will want to take over the ByTowne business and offer independent cinema to the ByTowne's wonderful fan base," he wrote. "But it's a scenario that's unlikely until we get out of the eye of the pandemic storm. If there's eventual interest from someone, you may see ByTowne 2.0 someday. No-one will be more delighted than me, and I'll be there as one of you, a happy spectator of amazing movies. But I won't be your programmer."
White has made plans to refund those who recently purchased memberships or vouchers, and has asked fans of the ByTowne to contribute to a Staff Appreciation Fund that will be equitably distributed to the theatre's 15 employees. He also urged theatregoers, "When post-pandemic life improves, attend any cinema, see any movie. Take chances; take friends; take a night off from Netflix."
The ByTowne Cinema first opened as the Nelson Theatre in 1947, and as the theatre's website mentions, a full-page newspaper ad announcing its arrival in capital touted "all the modern conveniences, including an air conditioning system and the very best in 'terrazzo' flooring."
Two years after opening, the Nelson was leased to Famous Players, who handled screenings for nearly 40 years. Upon the company making the move to multiplexes in 1988, the theatre became the ByTowne.
On a personal note, I am heartbroken, not only because I losing my job here, but also my second home. Much love to the employees of the ByTowne, past and present, and to our loyal and lovely customers for standing by us during this insurmountably challenging time.
— ByTowne Cinema (@ByTowne) December 4, 2020

redpajama_set_name: RedPajamaCommonCrawl


text:
Agency ID 325
Title Beenleigh Shire Council
Agency Type Local government authority
End Date 10/6/1949
Created under the Local Government/Authorities Acts to provide local administration and public services outside of major urban areas
10779 Poundkeeper's Sale Book 13/3/1903 30/9/1911
10774 Rate Books 13/3/1903 31/12/1911
5469 General Ledgers 13/3/1903 1/7/1938
4471 Finance Committee Minute Books 13/3/1903 10/6/1949
5468 General Cash Books 13/3/1903 10/6/1949
4997 Valuation Registers 31/3/1903 31/12/1909
5459 Rate Cash Books 31/3/1903 31/12/1911
5458 Letterbooks 31/3/1903 2/9/1920
10773 Correspondence Regarding Yatala Bridge 31/3/1903 28/10/1943
20515 Beenleigh Cemetery Records 31/3/1903 10/6/1949
9545 Town, Parish and Estate Maps 31/3/1903 10/6/1949
4469 Minute Books 31/3/1903 18/8/1949
9526 Special Accounts Cash Books 23/12/1911 11/12/1948
5465 Valuation and Rate Books 1/1/1912 10/6/1949
9543 Pound Keeper's Book 3/2/1919 7/6/1930
17095 Receipt and Expenditure Summary Books 1/1/1927 11/12/1948
10776 Minutes of Truck Committee 12/1/1927 18/9/1929
9534 Divisional Account Book 1/7/1937 30/6/1938
9537 Budget Ledgers 1/7/1937 30/6/1942
17092 Ledger Account Book 1/7/1937 30/6/1949
9542 Minutes of the Works Committee 7/4/1938 5/7/1938
9535 Fund Book 31/7/1938 31/5/1939
10778 Cash Per Post Book - Inwards 30/11/1938 9/10/1945
9539 Private Job Ledger 1/7/1941 8/6/1949
10775 Attendance Book 9/10/1941 9/10/1947
123 Home Secretary's Office 31/3/1903 5/12/1935
126 Health and Home Affairs Department 5/12/1935 10/12/1941
231 Local Government Department I 10/12/1941 11/12/1948
324 Beenleigh Divisional Board
1448 Nerang Shire Council
290 Albert Shire Council
Local Authorities Act of 1902
Queensland Government Gazette Vol CLVII, No 157, 13 Dec 1941 p1998
Queensland Government Gazette 11 Dec 1948, Vol. CLXXI, No. 21, p 3020
Establishing Local Authorities Act of 1902
Abolishing
Administered Local Authorities Act of 1902
ESTABLISHMENT:
The Local Authorities Act 1902 abolished divisional boards and created city, town and shire councils. Under this Act, Beenleigh Divisional Board was abolished and its functions were transferred to Beenleigh Shire Council on 31 Mar 1903. An Order in Council dated 9 December 1948 changed the name to Albert Shire Council which took effect on 10 June 1949.
Under the Local Authorities Act 1902, the primary function of Shire Councils was to provide such public services and amenities as parks and reserves, cemeteries, libraries and recreational facilities, water and sanitation services, roads, bridges, wharves, street lighting, public health services (such as immunisations), licences and registrations for businesses, markets and animals, town planning, and the control of noxious weeds and other pests.
The Council was also responsible for administering the Local Fund, and for valuing properties within the Shire for the purpose of determining and collecting rates.
The Council could pass by-laws regarding all matters within its jurisdiction. All such by-laws required the assent of the Governor-in-Council.
ADMINISTRATIVE STRUCTURE:
The Shire Council included a chairman, town clerk and a number of other members. From time to time, the Council could appoint committees for special or general purposes. Council also appointed its own officers, who were paid from the Local Fund.
Each year the Minister appointed an independent auditor to review the financial statements of the Council. The Council submitted an annual Statement of Revenue and Expenditure to the Minister, which was published in the Government Gazette.
PORTFOLIO CONTROLLING:
Home Secretary 31 Mar 1903 - 5 Dec 1935
Secretary for Health and Home Affairs 5 Dec 1935 - 23 Dec 1941
Secretary for Public Works 23 Dec 1941 - 15 May 1947
Secretary for Public Works, Housing and Local Government 15 May 1947 - 11 Dec 1948
Queensland State Archives Agency ID325, Beenleigh Shire Council


text:
Sorry, there are no results!
Advanced SearchSee all results for
Karma Hunters
About IGDB
Kidou Senshi Gundam F91: Formula Senki 0122
Make a recommendation
20 Games Like Kidou Senshi Gundam F91: Formula Senki 0122(TBA)
Polaris Sector
Can anyone build an empire in a place like this? Other factions are naturally suspicious of newcomers and may wage war at the first sign of unidentified craft. Here, a natural death is an uncommon luxury.
Was this recommendation...?
50 / 10012.5
Sol 0: Mars Colonization
Sol 0 is a real time strategy game where you establish the first Martian colony. From the first human footprints on Martian soil to a thriving and self-sustaining colony, Sol 0 imagines a near future using technology that could be available within the next few decades. Make use of minerals and resources across the Martian surface to expand from the first exploratory rover to an independent frontier.
Planetbase
Guide a group of space settlers trying to establish an outpost on a remote planet. Grow food, collect energy, mine resources, manufacture bots, and build a fully self-sufficient colony.
76 / 100103.8
StarDrive 2
StarDrive 2 is a 4X Turn Based Strategy game built in the classic style of the singular and incredible Master of Orion 2. In StarDrive 2 you will explore a vibrant galaxy filled with danger and intrigue in a deep turn-based strategy layer. You will design custom spaceships and deploy them into real-time battles with spectacular graphics and effects. You will conquer worlds in a turn-based tactical ground combat mode. You'll deal with aliens, pirates, monsters, and ancient threats, most of whom want to kill you to make room for their own empires.
StarDrive 2 also features a "Battle Arena" mode where you can get right to the action by designing ships and playing through story-based campaigns with your fleet. Earn money as you work through the challenges to unlock new ships and weapons.
And of course, you can customize your race for a unique experience, engage in deep diplomatic negotiations, research hundreds of different technologies (or maybe steal them with your spies), control strategic resources for the benefit of your empire, enslave enemy citizens, build armies of giant mechs, and so much more.
In the end, StarDrive 2 provides a comprehensive and beautiful 4X experience. Check out our screenshots and our videos and come join us on the forums. We have a large and active community and would love to have you come share your thoughts and questions with us.
Soul-Arena
Online browser multiplayer game based on anime Bleach.
Distant Worlds: Universe
Distant Worlds: Universe is the newest chapter of this critically acclaimed sci-fi series, adding incredible new features and an exciting new storyline. Universe is also the ultimate collector's edition, the first time all previous Distant Worlds releases have been included in one package, along with an updated manual and greatly expanded modding support.
Unclaimed World
We take the colony sim genre into the near future, onto a lush planet where humans are making their first foothold. Characters and alien wildlife are brought to life through a rigorous simulation and the game plays out as a tug-of-war between humans and nature on a planet full of opportunities and dangers.
Understanding the alien environment is crucial - discovered resources and crafting options enable you to adapt when food gets scarce, equipment breaks and alien animals attack.
Explore a vast galaxy full of wonder! Paradox Development Studio, makers of the Crusader Kings and Europa Universalis series presents Stellaris, an evolution of the grand strategy genre with space exploration at its core.
Featuring deep strategic gameplay, an enormous selection of alien races and emergent storytelling, Stellaris has a deeply challenging system that rewards interstellar exploration as you traverse, discover, interact and learn more about the multitude of species you will encounter during your travels.
Etch your name across the cosmos by uncovering remote celestial outposts,and entire civilizations. Will you expand through war or walk the path of diplomacy to achieve your goals?
You are a representative of the CRAFT & Co company. You are selling automated fabrication tools across the galaxy when your spacecraft crashes into a hostile planet. Use the tools you sell and the local resources to build up all of what you'll need to survive and eventually be able to escape the planet.
Sid Meier's Starships
Sid Meier's Starships challenges players to build a planetary federation by exploring the galaxy, expanding its influence and domain, researching futuristic technologies and engaging in deep, turn-based tactical space combat with an armada of uniquely customizable starships. Each new campaign will feature its own distinctive galactic strategy map of worlds with dynamically generated tactical combat missions that will enhance the game's replay value. In addition, Sid Meier's Civilization: Beyond Earth fans who purchase Sid Meier's Starships will uncover cross-connectivity with the two games such that will enhance and expand the depth of both game experiences.
67 / 10043.35
A sci fi colony sim driven by an intelligent AI storyteller.
RimWorld follows three survivors from a crashed space liner as they build a colony on a frontier world at the rim of known space. Inspired by the space western vibe of Firefly, the deep simulation of Dwarf Fortress, and the epic scale of Dune and Warhammer 40,000.
Manage colonists' moods, needs, thoughts, individual wounds, and illnesses. Engage in deeply-simulated small-team gunplay. Fashion structures, weapons, and apparel from metal, wood, stone, cloth, or exotic, futuristic materials. Fight pirate raiders, hostile tribes, rampaging animals and ancient killing machines. Discover a new generated world each time you play. Build colonies in biomes ranging from desert to jungle to tundra, each with unique flora and fauna. Manage and develop colonists with unique backstories, traits, and skills. Learn to play easily with the help of an intelligent and unobtrusive AI tutor.
Last Days of Old Earth
Last Days of Old Earth is a rich strategy game set in our far, far future where the sun is dying. Can you command the last noble tribes of humanity as they attempt to survive among the machines and marauding clans?
Naruto Arena
Online browser multiplayer game based on anime Naruto.
Ashes of the Singularity is a real-time strategy game set in humanity's not-so-distant future. What it means to be human has changed with the coming of the singularity.
In the post-human economy, sentience is now the most valuable commodity in the universe. The only way to acquire more of that is through the control of Turinium – programmable matter – which can extend consciousness to levels we can't even imagine. Worlds are being transformed into this substance and wars are now being fought across the galaxy for control of those worlds.
Each conflict takes place across an entire world. It isn't a skirmish. It's a war. Thousands of units are constantly constructed and sent across the planet with the player directing entire armies, in real time, to capture key resources in an effort to gain total control of the planet.
Homeworld: Remastered Collection
Homeworld Remastered Collection updates and introduces the landmark space strategy games to modern audiences. The collection includes Homeworld and Homeworld 2, painstakingly remastered by Gearbox in cooperation with key members of the original development team and members of the series' passionate fan community. As a free bonus, this collection also includes the original versions of Homeworld and Homeworld 2 with compatibility updates, preserving the purest form of the original releases. Anyone who purchases Homeworld Remastered Collection will also receive free access to the Homeworld Remastered Steam Multiplayer Beta when the collection releases on February 25, 2015.
The Homeworld series has a long legacy and is regarded by many as one of the best strategy series of all time. Following its release in 1999 by publisher Sierra and developer Relic Entertainment, Homeworld received several Game of the Year awards and redefined the RTS genre. Its sequel, Homeworld 2, launched in 2003, and was similarly praised by critics for its innovative controls and changes to multiplayer. Brian Martel, Gearbox Software's Chief Creative Officer, has great love and respect for Relic's brilliant, fun and innovative franchise and personally spearheaded Gearbox Software's acquisition of Homeworld from THQ in 2013.
99 / 100314.95
Welcome to the dawn of the industrial age. The path you choose will define your world. Are you renovator or exploiter? Suppressor or liberator? It's up to you how the world will remember your name.
In Anno 1800, players will take charge of their own fortune as they navigate the rapidly evolving technological and malicious political landscape of the 19th century in their quest to build an empire that will stand the test of time.
Combining beloved features with innovative gameplay in a memorable new setting, Anno 1800 marks the beginning of a new era for the Anno franchise.
Sovereignty: Crown of Kings
The old Empire is crumbling. Younger hungrier realms wait like vultures for their chance to pick at the carcass. Thus begins the grand campaign of Sovereignty. Rule your realm wisely and decisively. Play as the Boruvian Empire and try to recapture former Imperial glories. Or play any of 34 other realms, each with their own rich history, culture and play-style.
The Long Journey Home combines the endless freedom of space with a new open questing system that always leaves you in command. Deliver the stranded Glukkt to his homeworld as he asks, or to your new slaver friends? Attempt to make allies with everyone, or pin your hopes on the tougher races, and hope they never turn on you? Jump by jump, make hard decisions and live with the consequences, in a universe that is never the same twice.
Medieval Kingdom Wars
Rewrite medieval history through bloody siege combat and grand strategy. Rule, build, and wage war as one of the minor lords of medieval Europe… Medieval Kingdom Wars redefines Medieval Grand Strategy. Build your cities, wage your wars, serve your king, and experience siege combat with a degree of brutality never seen before
Startup Company is a business simulation sandbox game. You play as the CEO of a newly formed software company. Your job is to either complete client contracts to make money, or build your very own products.
About us-Blog-Privacy -Terms-Copyright Policy - API
© 2019 8 Dudes in a Garage AB ALL RIGHTS RESERVED
Request mobile siteBack to Top
© 2019 - 8 Dudes in a Garage AB ALL RIGHTS RESERVED
Terms Service - Copyright Policy - API


March 15, 2007 -- There is widespread concern that antidepressants may increase suicide risk, but an Italian psychiatric disorders expert says this may only be true when the drugs are used incorrectly.
Because the disorder is so often misdiagnosed, patients are often wrongly treated with antidepressants alone, which can make the problem worse, the professor of psychiatry tells WebMD.
"These patients need to be on mood-stabilizing drugs, and if depression persists an antidepressant can be added," Benazzi says. "Treating these patients with antidepressants alone can actually increase the manic episodes and worsen the disorder."
Once known as manic depression, bipolar disorder is characterized by dramatic mood swings in which patients experience extreme highs and extreme lows. Bipolar disorder II is considered a less severe form of the disease, with mild to moderate levels of mania known as hypomania.
Patients with bipolar I may have psychotic episodes, but hallucinations and delusions do not occur with bipolar II.
Because mood swings are less obvious than with bipolar I, diagnosing bipolar disorder II remains a challenge. Patients often suffer from depression as well and that is why so many are treated only with antidepressants.
"The depression is recognized, but the bipolar disorder is not," Benazzi says.
The problem may be especially common in children and adolescents.
"Misdiagnosis of bipolar disorder as attention deficit hyperactivity disorder [ADHD] and major depressive disorder is common, leading to the use of stimulants and antidepressants, which might worsen the course instead of mood-stabilizing agents," he notes.
Benazzi writes that patients who show symptoms of what appears to be depression should be evaluated for manic or hypomanic symptoms. If bipolar disorder is diagnosed, treatment should include mood-stabilizing drugs like lithium, with or without antidepressants.
The widespread use of antidepressants alone in patients with mixed depression may explain the reported increase in suicides among patients on these drugs.
"The suicidality sometimes related to antidepressants is probably not caused by the [drugs], but by clinicians using only antidepressants to treat mixed depression," Benazzi concludes.
Researcher Rif S. El-Mallakh, MD, of the University of Louisville School of Medicine, says clinicians have gotten better in recent years at identifying bipolar disorder II. But he adds that too many patients are still being improperly treated.
El-Mallakh, who is an associate professor of psychiatry, tells WebMD that in addition to increasing the frequency of manic or hypomanic episodes, antidepressants can worsen depression and increase the likelihood of future depression.
When bipolar patients experience four or more manic or hypomanic or depression episodes within a year it is known as rapid cycling.
Prior to the introduction of antidepressants, rapid cycling was quite rare in bipolar disorder, occurring in just 2% to 3% of patients, El-Mallakh says. These days, he adds, 20% to 25% of patients experience rapid cycling.
The researchers agree that more research on bipolar disorder II and the related spectrum of disorders is needed.
Benazzi points to studies suggesting that on average patients with bipolar disorders are misdiagnosed for eight to 10 years before their disease is correctly identified.
"Depression tends to get worse as the disorder progresses, especially if patients are taking the wrong drugs for many years," he says.
SOURCES: Benazzi, F. The Lancet, March 17, 2007; vol 369: pp 935-945. Franco Benazzi, MD, PhD, professor of psychiatry, Hecker Psychiatry Research Center, Forli, Italy. Rif S. El-Mallakh, MD, assistant professor of psychiatry, University of Louisville School of Medicine, Louisville, Ky.


There are 10 critical elements of the care coordination model for Independent Health Care Plan (iCare) Medicaid managed care members, according to Lisa Holden, vice president of accountable care, iCare.
Care coordinators are assigned to every Medicaid member and are responsible for engaging and coordinating member's care needs.
Once completed, the health risk assessment forms the basis of an interdisciplinary individualized care plan created by the care coordinator with the member.
The care coordinator, who is a social worker by background, has access to a nurse, who is available for medically complex members, said Holden.
iCare also relies on health coaches. Health coaches are now teaming up with a care coordinator as much as, if not more than, the nurses are historically, Holden said.
The health coaches also help the care coordinators locate difficult-to-contact members by being in the community as a boots on the ground force. They're also focused on assessing and addressing social determinants of health.
"We really believe that health coaches are going to be the key to our success in this year and in years to come," Holden explained.
In addition to the care coordinators, health coaches and nurses, the care coordination team includes two specialized positions…a trauma-informed intervention specialist and a mental health and substance abuse intervention specialist. "We brought those two specialties into this program for our Medicaid members because we know that there's a high instance of behavioral health conditions, which usually has another diagnosis of alcohol and drug use, not always, but quite often. We wanted to have the team ready to engage the member," said Holden.
iCare uses the Patient Activation Measure tool to help identify where the member is in a spectrum of four different levels of activation. iCare then tailors its member engagement approach to build a trusting relationship and provide member education by recognizing where they are in their activation level.
Following up on preventive measures are key for the iCare care coordination model. Care coordinators reach out to members for care plan updates. The care plan has to be alive and very member-centric, said Holden. The health risk assessment is repeated each year and the care plan is updated based on those results.
iCare is also focusing on social determinants of health with the recognition that they impact a members' health more than clinical care. Clinical care attributes to only about 20 percent of somebody's health outcomes; the rest of that 80 percent is made up of by health behaviors, social and economic factors, and physical environment. "If we don't get underneath those issues, we can ask for things to improve, but we're going to see minimal success," Holden added.
During the webinar, Holden also shared: how the care coordinators helps Medicaid members overcome barriers to care; seven rising risk/acuity identification tools; readmission prevention initiatives for high-risk patients; three programs aimed at reducing high emergency department utilization; and details on a Follow-to-Home program for members who are homeless. Holden also shared: details on language to use…and not to use…when engaging members; advice on the best time to connect with members by phone, such as time of day, specific days of the months; the role of the specialist interventionist compared to the care coordinator; and the background of iCare's care coordinators and health coaches.
Click here to view the webinar today or order a DVD or CD of the conference proceedings.
Community health partnerships address unmet needs, providing services related to transportation, housing, nutrition and behavioral health.
For residents of some locales, community health partnerships (CHP) —alliances between healthcare providers and local organizations to address unmet needs—can mean the difference between surviving and thriving, according to new CHP metrics from the Healthcare Intelligence Network (HIN).
"We could not survive without community partnerships. Our patients thrive because of them. They are critical to help change the culture of poverty that remains in our community," noted a respondent to HIN's 2017 survey on Community Health Partnerships.
Partnerships can also mean the difference between housing and homelessness. According to the survey, more than a quarter of community health partnerships (26 percent) address environmental and social determinants of health (SDOH) like housing and transportation that can have a deleterious effect on population health.
"To date, we have housed 49 families/individuals who were formally homeless or near homelessness," added another respondent.
Motivated to improve population health, healthcare providers are joining forces with community groups such food banks, schools and faith-based organizations to bridge care gaps and deliver needed services. The majority of community health partnerships are designed to improve access to healthcare, say 70 percent of survey respondents.
Eighty-one organizations shared details on community health partnerships, which range from collaborating with a local food bank to educate food pantries on diabetes to the planting of community gardens to launching an asthma population health management program for students.
Seventy-one percent conduct a community health needs assessment (CHNA) to identify potential areas for local health partnerships. Priority candidates for 36 percent of these partnerships are high-risk populations, defined as those having two or more chronic medical conditions.
Overall, the survey found that 95 percent of respondents have initiated community health partnerships, with half of those remaining preparing to launch partnerships in the coming year.
Local organizations such as food banks top the list of community health partners, say 79 percent.
The population health manager typically has primary responsibility for community health partnerships forged by 30 percent of respondents.
Foundations are the chief funding source for services offered through community health partnerships, say 23 percent. However, funding remains the chief barrier to community health partnerships, say 41 percent.
Forty-five percent have forged community health partnerships to enhance behavioral health services.
Two-thirds attributed increases in clinical outcomes and quality of care to community health partnerships.
Forty-four percent reported a drop in hospital ER visits after launching community health partnerships.
Download an executive summary of results from the 2017 Community Health Partnerships survey.
Malnutrition is a social determinant of health that negatively impacts health outcomes.
It's a difficult statistic to digest: one in three people enter the hospital malnourished or at risk of malnutrition, a state that impacts their recovery and increases their risk of health complications and rehospitalizations.
Two studies this week highlight the clinical benefits of addressing patients' nutrition needs before and during hospital stays as well as savings that can result from identification of social determinants of health (SDOH) like access to nutrition that drive 85 percent of health outcomes.
In the first, a study of elderly Maryland residents by Benefits Data Trust, a national nonprofit based in Philadelphia, found that when it comes to low-income seniors, access to quality food via food stamps can also save money by reducing the number and duration of hospital visits and nursing home admissions.
In the second, research published in American Health & Drug Benefits journal and supported by Abbott found that when Advocate Health Care implemented a nutrition care program at four of its Chicago area hospitals, it showed more than $4.8 million in cost savings due to shorter hospital stays and lower readmission rates.
The Benefits Data Trust research found that participation by low-income seniors in the federal Supplemental Nutrition Assistance Program (SNAP) cut their odds of hospital admissions by 14 percent. The food stamps also reduced the need for ER visits by 10 percent, and cut their likelihood of going into a nursing home by nearly one quarter.
Finally, SNAP participation also led to an 8 to 10 percent drop in the number of days a patient who was admitted remained in one of these facilities.
As a result, hospitals and health care systems such as Advocate Health Care are looking at the value of nutrition to improve care and help patients get back to living a healthier life.
Starting in 2014, Advocate Health Care, the largest health system in Illinois and one of the largest accountable care organizations (ACO) in the country, implemented two models of a nutrition care program for patients at risk of malnutrition. The nutrition-focused quality improvement program, which targeted malnourished hospitalized patients, consisted of screening patients with a validated screening tool at admission, rapidly administering oral nutritional supplements, and educating patients on supplement adherence.
The leader in population health found that by doing so, it reduced 30-day readmission rates by 27 percent and the average hospital stay by nearly two days.
More recently, to evaluate the cost-savings of the Advocate approach, researchers used a novel, web-based budget impact model to assess the potential cost savings from the avoided readmissions and reduced time in hospital. Compared to the hospitals' previous readmission rates and patients' average length of stay, researchers found that optimizing nutrition care in the four hospitals resulted in roughly $3,800 cost savings per patient treated for malnutrition.
Given the healthcare industry's appetite for value- and quality-based programs, SDOH screenings and the fortification of nutrition programs in both community and inpatient settings appear to be just what the doctor ordered. However, while a 2017 study on Social Determinants of Health identified widespread adoption of SDOH screenings by providers, it also documented a scarcity of supportive community services for SDOH-positive individuals.
Montefiore Health Systems screens patients for social determinants of health, which drive 85 percent of a person's well-being.
Montefiore Health System's two-tiered assessment screening program to measure social determinants of health (SDOH) positivity in its predominantly high-risk, government-insured population is inspired by existing initiatives within its own organization. Here, Amanda Parsons, MD, MBA, vice president of community and population health at Montefiore Health System, describes the planning that preceded Montefiore's SDOH screening rollout.
I'd like to explain how we came to implement the social determinants of health screening. Many of us in New York State participate in the delivery system or full-on incentive program. It is that program that has enabled us to step back and think about using Medicaid waiver dollars to invest in the things that make a difference.
I need not tell anybody in this industry: many studies have looked at what contributes to health. We know that clinical health in and of itself contributes somewhere between 10 to 15 percent of a person's well-being; however, so much more of their health and well-being is driven by other factors, like their environment and patient behaviors. And yet, we had not had a chance in the healthcare system to really think about what we wanted to do about that. It was really the Delivery System Reform Incentive Payment (DSRIP) program that has allowed us to start exploring these new areas and think about how we want to collectively address them in our practices.
Assessing Social Determinants of Health: Screening Tools, Triage and Workflows to Link High-Risk Patients to Community Services outlines Montefiore's approach to identifying SDOH markers such as housing, finances, healthcare access and violence that drive 85 percent of patients' well-being, and then connecting high-need individuals to community-based services.
The complexity and intensity of treatment for lower back pain may vary depending on how likely it is that the patient will have a good, functional outcome, according to a new infographic by BMJ Publishing Group.
The infographic provide care pathways for patients by expected outcome.
When success in a fee-for-value reimbursement framework calls for a care coordination vision focused on the highest-risk, highest-cost patients, an organization must be able to identify this critical population.
2016 Healthcare Benchmarks: Stratifying High-Risk Patients captures the latest tools and practices employed by healthcare organizations across the care continuum as they risk-stratify patients and health plan members in preparation for care management.
The social determinant of social isolation carries the same health risk as smoking, and double that of obesity.
With about a third of health outcomes determined by human behavior choices, according to a Robert Wood Johnson Foundation study, improving population health should be as straightforward as fostering healthy behaviors in patients and health plan members.
But what's unstated in that data point is that the remaining 70 percent of health outcomes are determined by social determinants of health—areas that involve an individual's social and environmental condition as well as experiences that directly impact health and health status.
By addressing social determinants, healthcare organizations can dramatically impact patient outcomes as well as their own financial success under value-based care, advised Dr. Randall Williams, chief executive officer, Pharos Innovations, during Social Determinants and Population Health: Moving Beyond Clinical Data in a Value-Based Healthcare System, a December 2016 webinar now available for replay.
The Medicare annual wellness visit is an ideal opportunity to screen beneficiaries for social determinants—particularly rising and high-risk patients, who frequently face a higher percentage of social determinant challenges.
Primary social determinants include the individual's access to healthcare, their socio- and economic conditions, and factors related to their living environment such as air or water quality, availability of food, and transportation.
Dr. Williams presented several patient scenarios illustrating key social determinants, including social isolation, in which individuals, particularly the elderly, are lonely, lack companionship and frequently suffer from depression. "Social isolation carries the same health risk as smoking and double that of obesity," he said.
While technology is useful in reducing social isolation, studies by the Pew Research Center determined that segments of the population with the highest percentage of chronic illness tend to be least connected to the Internet or even to mobile technologies.
In another patient scenario, loss of transportation severely hampered an eighty-year-old woman's ability to complete physical rehabilitation following a knee replacement.
Dr. Williams then described multiple approaches for healthcare organizations to begin to address social determinants in population health, including patients' cultural biases, which may make them more or less open to specific care options. This fundamental care redesign should include an environmental assessment to catalog available social and community resources, he said, providing several examples.
"This is not the kind of information you're going to find in a traditional electronic health record or even care management platforms," he concluded.
Assuring data integrity is the top challenge to health risk stratification, according to a July 2016 healthcare benchmarks survey.
Two key trends emerging from a July 2016 survey on Stratifying High-Risk Patients highlight the need to occasionally eschew sophisticated tools in favor of basic, face-to-face care coordination.
The first learning gleaned from the survey's 112 respondents is that, despite the prevalence of high-end risk predictors, algorithms and monitoring tools, clinicians must occasionally step into the patient's world—that is, literally enter their home—in order to capture the individual's total health picture.
Fifty-six percent of respondents make home visits to risk-stratified patients; a half dozen identified the home visit as its most successful intervention for risk-stratified populations.
That inside look at the patient environment illuminates data points an electronic health records (EHRs) might never bring to light, including socioeconomic factors like limited mobility that could prevent a patient from keeping a follow-up appointment.
"I never know until the moment I enter the home and actually see what the environment is like whether we correctly predicted the need for high intervention (and get a return on it)," commented one respondent.
The second trend in risk stratification is the emerging laser focus on 'rising risk' patients, an activity reported by 72 percent of respondents. This scrutiny of rising risk populations helps to prevention their migration to high-risk status, where complex and costly health episodes prevail.
Almost four-fifths of 2016 respondents have programs to stratify high-risk patients, and the infrastructures of more than half of these initiatives utilize clinical analytics, predictive algorithms, EHRs and other IT tools to manage care for high-risk patients.
The reigning health risk calculator continues to be the LACE tool (Length of stay, Acute admission, Charleston Comorbidity score, ED visits), used by 45 percent in 2016, versus 33 percent two years ago.
For more than a quarter of 2016 respondents, assuring data integrity remains a key challenge to risk prediction.
A case manager typically has primary responsibility for risk stratification, say 52 percent of respondents.
Diabetes is the most prevalent clinical condition among high-risk patients, say 47 percent.
At least 70 percent report reductions in hospitalizations and ER visits related to risk stratification efforts.
Improvement in the highly desirable metric of patient engagement is reported by 74 percent of respondents.
Click here to download an executive summary of survey results: Stratifying High-Risk Patients in 2016: As Risk Prediction Prevails, Industry Eyes Social Determinants, Rising Risk.
Collaborative Health Systems, the largest sponsor of Medicare ACOs in the United States, recently rolled out an analytics and dashboard portal for its 3,200 providers.
In 2016, CMS expects 30 percent of Medicare fee-for-service (FFS) reimbursement to be tied to alternative payment models such as accountable care and bundled payments.
Also this year, the federal payor wants 85 percent of Medicare FFS payments to be based upon quality metrics.
Ms. Tkachev detailed the power of data analytics to drive CHS's success in accountable care during Data Analytics in Accountable Care: Strategies and Case Studies, a January 2016 webinar from the Healthcare Intelligence Network now available for replay.
As the largest sponsor of Medicare Shared Savings Program (MSSP) ACOs in the United States, CHS has a firm handle on HHS's value-based agenda. The organization manages 24 MSSP ACOs, nine of which generated savings of nearly $27 million in 2014, and one that has been accepted as a Next Generation ACO, the newest Medicare accountable care model.
And with CMS expectations for value-based reimbursement slated to rise over the next two years, expectations for data analytics to improve care and costs related to Medicare beneficiaries have never been higher.
Despite the magnitude of its enterprise, CHS believes its future in accountable care rests upon its primary care physicians (PCPs), which it views as "quarterbacks of care" for its more than 280,000 Medicare beneficiaries.
To foster quality improvement, CHS equips PCPs with an arsenal of analytics capabilities. So that its 3,200 providers can tap into CHS's massive storehouse of CMS, claims, lab, risk stratification and care coordination data collected on its 24 Medicare Shared Savings Program (MSSP) ACOs, the health system recently rolled out an analytics and dashboard portal.
These tools enable providers to monitor the aggregate health of their populations as well as their own performance, even giving providers the ability to track their own performance over time and contrast it with other clinicians'—a capability that pleases CHS's more competitive physicians, Ms. Tkachev notes.
Frequent webinar training keeps provider analytics' use sharp, and dashboard-generated reports and scorecards help physicians to monitor and enhance quality performance and improve patient outreach, Ms. Tkachev explained.
Despite its significant success, CHS still encounters the perennial challenges of access to timely and accurate data, aggregation abilities, and the display of meaningful results. Ms. Tkachev shared some CHS tactics to resolve these issues, including soliciting feedback on the tools from providers who use them.
Listen to an interview with Elena Tkachev on data analytic's potential to drive annual wellness visits and boost beneficiary attribution.


Make a search to see a sample of results.
Just sign up for FREE and unlock the number of results you can get access to. Free registration gives you also access to more details information on each company.


text:
Q: Is it a good idea to use xib files in storyboard I have a project which is based on storyboard. The problem is some views are repeated in some view controllers.
I created xib file for these repeated views and then I use don't create theses view again. I just add a uiview and set its class to the custom view I have created.
It work ok as it avoids repeated view changes.
But I don't know if this cause performance or any other problems later.
And I cannot change the whole project to only use with xib files.

A: one of the clean code goals is to reuse your code. so base on this, xib file is a good solution, but about performance, using interface builder has less performance than implementation through code. if you are concern too much about performance, use the code, if not, your implementation is ok.

A: If your project has similar kind of design or view then yes using xib with storyboard is good. you can reduce redundancy by taking similar kind of view or Tableview cell or collectionview cell. that will also make your storyboard neat and clean.
you can check this and based on that you can use as per your requirement.
Which is more efficient way? StoryBoard or XIB?

redpajama_set_name: RedPajamaStackExchange


text:
Vol. 36 No. 2 (2021): November Issue /
Discordance between Fasting Plasma Glucose (FPG) and HbA1c in Diagnosing Diabetes and Pre-diabetes in The Malaysian Cohort
Nor Azian Abdul Murad UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia
Noraidatulakma Abdullah UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia https://orcid.org/0000-0002-7186-2455
Mohd Arman Kamaruddin UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia https://orcid.org/0000-0002-6157-4003
Nazihah Abd Jalal UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia https://orcid.org/0000-0001-9649-0048
Norliza Ismail UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia https://orcid.org/0000-0002-4707-7748
Nurul Ain Mhd Yusof UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia
Norlaila Mustafa Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia https://orcid.org/0000-0002-0196-7091
Rahman Jamal UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia https://orcid.org/0000-0002-8354-8957
https://doi.org/10.15605/jafes.036.02.02
type 2 diabetes mellitus, fasting plasma glucose, HbA1c, The Malaysian Cohort, diagnosis, population differences
Objective. In this present study, we aim to evaluate the accuracy of the HbA1c relative to fasting plasma glucose (FPG) in the diagnosis of diabetes and pre-diabetes among The Malaysian Cohort (TMC) participants.
Methodology. FPG and HbA1c were taken from 40,667 eligible TMC participants that have no previous history of diabetes, aged between 35-70 years and were recruited from 2006 – 2012. Participants were classified as normal, diabetes and pre-diabetes based on the 2006 World Health Organization (WHO) criteria. Statistical analyses were performed using ANOVA and Chi-square test, while Pearson correlation and Cohen's kappa were used to examine the concordance rate between FPG and HbA1c.
Results. The study samples consisted of 16,224 men and 24,443 women. The prevalence of diabetes among the
participants was 5.7% and 7.5% according to the FPG and HbA1c level, respectively. Based on FPG, 10.6% of the
participants had pre-diabetes but this increased to 14.2% based on HbA1c (r=0.86; P<0.001). HbA1c had a sensitivity of 58.20 (95% CI: 56.43, 59.96) and a specificity of 98.59 (95% CI: 98.46, 98.70).
Conclusion. A higher prevalence of pre-diabetes and diabetes was observed when using HbA1c as a diagnosis tool, suggesting that it could possibly be more useful for early detection. However, given that HbA1c may also have lower sensitivity and higher false positive rate, several diagnostic criteria should be used to diagnose diabetes accurately.
Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Science. 2006;1084:1-29. https://pubmed.ncbi.nlm.nih.gov/17151290. https://doi.org/10.1196/annals.1372.029.
Institute for Public Health (IPH) 2015. National Health and Morbidity Survey 2015 (NHMS 2015). Non-communicable diseases, risk factors and other health problems. Vol. 2. Kuala Lumpur, Malaysia. 2015;1-315. Available from: https://www.moh.gov.my/moh/resources/nhmsreport2015vol2.pdf.
Jamal R, Syed Zakaria SZ, Kamaruddin MA, et al. The Malaysian Cohort (TMC) project: A prospective study of non-communicable diseases in a multiethnic population. Int J Epidemiology. 2015;44(22):423-31. https://pubmed.ncbi.nlm.nih.gov/24729425. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469794. https://doi.org/10.1093/ije/dyu089.
Institute for Public Health (IPH) 2019. National Health and Morbidity Survey 2019 (NHMS 2019). National Health and Morbidity Survey 2019. Non-communicable diseases, healthcare demand, and health literacy. Key findings. Available at http://www.iku.gov.my/nhms.
Ashraf S. Diagnosis of type 2 diabetes using serial fasting plasma glucose versus HbA1c in the primary care setting. Aust J Gen Pract. 2019;48(5):269-71. https://pubmed.ncbi.nlm.nih.gov/31129936. https://doi.org/10.31128/AJGP-07-18-4652.
Modhumi Khan RM, Yu Chua ZJ, Tan JC, Yang Y, Liao Z, Zhao Y. From pre-diabetes to diabetes: Diagnosis, treatments and translational research. Medicina (Kaunas). 2019;55(9):546. https://pubmed.ncbi.nlm.nih.gov/31470636. https://pubmed.ncbi.nlm.nih.gov/PMC6780236. https://doi.org/10.3390/medicina55090546.
Ye Y, Xie H, Zhao X, Zhang S. The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: A meta-analysis of diagnostic test accuracy. Cardiovasc Diabetol. 2012; 11:155. https://pubmed.ncbi.nlm.nih.gov/23270530. https://pubmed.ncbi.nlm.nih.gov/PMC3534587. https://doi.org/10.1186/1475-2840-11-155.
Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: Abbreviated report of a WHO Consultation. Geneva: World Health Organization. 2011. https://pubmed.ncbi.nlm.nih.gov/26158184. Bookshelf ID:NBK304267.
KP Peterson, JG Pavlovich, D Goldstein. et al. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin Chem. 1998;44(9):1951–8. https://pubmed.ncbi.nlm.nih.gov/9732983.
Koenig RJ, Peterson CM, Jones RL et al. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med. 1976;295(8):417–20. https://pubmed.ncbi.nlm.nih.gov/934240. https://doi.org/10.1056/NEJM197608192950804.
Treviño G. Consensus statement on the worldwide standardization of the haemoglobin A1c measurement: The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation: Response to the Consensus Committee. Diabetes Care. 2007;30(12):e141. https://pubmed.ncbi.nlm.nih.gov/18042750. https://doi.org/10.2337/dc07-1752.
International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-34. https://pubmed.ncbi.nlm.nih.gov/19502545. https://pubmed.ncbi.nlm.nih.gov/PMC2699715. https://doi.org/10.2337/dc09-9033.
Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: Abbreviated report of a WHO consultation. Geneva: World Health Organization; 2011. Bookshelf ID:NBK304267/.
Wang B, Liu MC, Li XY, et al. Cutoff point of HbA1c for diagnosis of diabetes mellitus in Chinese individuals. PLoS One. 2016;18:11(11):e0166597. https://pubmed.ncbi.nlm.nih.gov/27861599. https://pubmed.ncbi.nlm.nih.gov/PMC5115764. https://doi.org/10.1371/journal.pone.0166597.
Nam HK, Cho WK, Kim JH, et al. HbA1c cutoff for prediabetes and diabetes based on oral glucose tolerance test in obese children and adolescents. J Korean Med Sci. 2018;19;33(12):e93. https://pubmed.ncbi.nlm.nih.gov/29542302. https://pubmed.ncbi.nlm.nih.gov/PMC5852422. https://doi.org/10.3346/jkms.2018.33.e93.
Wan Nazaimoon WM, Md Isa SH, Wan Mohamad WB, et al. Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion. Diabet Med. 2013; 30(7):825-8. https://pubmed.ncbi.nlm.nih.gov/23413941. https://doi.org/doi: 10.1111/dme.12161.
Lim WY, Ma S, Heng D, Tai ES, Khoo CM, Loh TP. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore. Sci Rep. 2018; 20;8(1):12419. https://pubmed.ncbi.nlm.nih.gov/30127499. https://pubmed.ncbi.nlm.nih.gov/PMC6102285. https://doi.org/10.1038/s41598-018-29998-z.
Herman WH, Dungan KM, Wolffenbuttel BHR, et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab. 2009; 94(5):1689-94. https://pubmed.ncbi.nlm.nih.gov/19276235. https://doi.org/10.1210/jc.2008-1940.
Ho-Pham LT, Nguyen UDT, Tran TX, Tran TX, Nguyen TV. Discordance in the diagnosis of diabetes: Comparison between HbA1c and fasting plasma glucose. PLoS ONE. 2017; 12(8): e0182192. https://pubmed.ncbi.nlm.nih.gov/28817663. https://pubmed.ncbi.nlm.nih.gov/PMC5560685. https://doi.org/10.1371/journal.pone.0182192.
Kim HK, Kim CH, Kim EU, Bae SJ, Park JY. Usefulness of hemoglobin A1c as a criterion of dysglycemia in the definition of metabolic syndrome in Koreans. Diabetes Res Clin Pract. 2012; 95(3):333-9. https://pubmed.ncbi.nlm.nih.gov/22071434. https://doi.org/10.1016/j.diabres.2011.10.012.
Unwin N, Howitt C, Mc Rose A, Samuels TA, Hennis AJ, Hambleton IR. Prevalence and phenotype of diabetes and prediabetes using fasting glucose vs H bA1c in a Caribbean population. J Glob Health. 2017;7(2):020407. https://pubmed.ncbi.nlm.nih.gov/28959440. https://pubmed.ncbi.nlm.nih.gov/PMC5604098. https://doi.org/10.7189/jogh.07.020407.
Hudson PR, Child DF, Jones H, Williams CP. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem. 1999; 36(Pt 4):451-9. https://pubmed.ncbi.nlm.nih.gov/10456207. https://doi.org/10.1177/000456329903600408.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care.2010; 33 (Suppl 1):S26-9. https://pubmed.ncbi.nlm.nih.gov/24357215. https://doi.org/10.2337/dc14-S081.
Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes. 2009;1(1):9-17. https://pubmed.ncbi.nlm.nih.gov/20923515. https://doi.org/10.1111/j.1753-0407.2009.00009.x
American Association of Clinical Endocrinologists/American College of Endocrinology Statement on the use of hemoglobin A1C for the diagnosis of diabetes. AACE/ACE Position Statement. 2010;16(2):155-6. https://doi.org/10.4158/EP.16.2.155.
Abdul Murad, N. A., Abdullah, N., Kamaruddin, M. A., Abd Jalal, N., Ismail, N., Mhd Yusof, N. A., Mustafa, N., & Jamal, R. (2022). Discordance between Fasting Plasma Glucose (FPG) and HbA1c in Diagnosing Diabetes and Pre-diabetes in The Malaysian Cohort. Journal of the ASEAN Federation of Endocrine Societies, 36(2), 127–132. https://doi.org/10.15605/jafes.036.02.02
Vol. 36 No. 2 (2021): November Issue
Copyright (c) 2021 Nor Azian Abdul Murad, Noraidatulakma Abdullah, Mohd Arman Kamaruddin, Nazihah Abd Jalal, Norliza Ismail, Nurul Ain Mhd Yusof, Norlaila Mustafa, Rahman Jamal
Gabriel Jasul Jr., Elizabeth Paz-Pacheco, Cecilia Jimeno, Ketut Suastika, Zanariah Hussein, Norlaila Mustafa, Aye Aye Aung, Jeremyjones Robles, Melvin Khee Shing Leow, Chaicharn Deerochanawong, Nguyen Thy Khue, Tran Huu Dang, AFES A.S.-O.N.E.: ASEAN Survey Of Needs in Endocrinology in the Time of the COVID-19 Pandemic , Journal of the ASEAN Federation of Endocrine Societies: Vol. 35 No. 1 (2020): May Issue
Cheow Peng Ooi, Norlaila Mustafa, Thean Yean Kew, Communicating Hydrocephalus in a Case of Long-Term Primary Hyperparathyroidism , Journal of the ASEAN Federation of Endocrine Societies: Vol. 33 No. 1 (2018): May Issue
Shamharini Nagaratnam, Malathi Karupiah, Norlaila Mustafa, Debilitating Pain and Fractures A Rare Case of Hypophosphatemic Osteomalacia with Concomitant Vitamin D Deficiency in Neurofibromatosis Type 1 , Journal of the ASEAN Federation of Endocrine Societies: Vol. 35 No. 1 (2020): May Issue
Cheow Peng Ooi, Nor Azmi Kamaruddin, Norlaila Mustafa, Thean Yean Kew, 'Houdini's Pituitary:' A Case Report of Regression of Pituitary Mass to Empty Sella in a 58-Year-Old Man with Autoimmune Hypophysitis , Journal of the ASEAN Federation of Endocrine Societies: Vol. 33 No. 1 (2018): May Issue
Malathi Kerpaiah Karupiah, Chin Siok Fong, Norlaila Mustafa, THE EFFECT OF LUSEOGLIFLOZIN ON CARDIOMETABOLIC MARKERS IN PATIENTS WITH PREDIABETES (IMPAIRED GLUCOSE TOLERANCE) , Journal of the ASEAN Federation of Endocrine Societies: Vol. 36 (2021): MAC11 Book of Abstracts
Noraidatulakma Abdullah, Azmawati Mohammed Nawi, Mohd Arman Kamaruddin, Nazihah Abd Jalal, Rahman Jamal, TYPE 2 DIABETES AND CANCER SCREENING , Journal of the ASEAN Federation of Endocrine Societies: Vol. 36 (2021): MAC11 Book of Abstracts
Mohd Rahman Omar, Norasyikin A Wahab, Rohana J Jaafar, Kang Waye Hann, Farhana Binti Ismail, Norlaila Mustafa, Norlela Sukor, Nor Azmi Kamaruddin, REAL-WORLD EXPERIENCE OF DULAGLUTIDE THERAPY IN A SINGLE TERTIARY CENTER , Journal of the ASEAN Federation of Endocrine Societies: Vol. 36 (2021): MAC11 Book of Abstracts
Felicia Lee Yiik Bing, Raja Aimee Raja Abdullah, Moey Lip Hen, Norlaila Mustafa, INS GENE MUTATION IN NEONATAL DIABETES MELLITUS , Journal of the ASEAN Federation of Endocrine Societies: Vol. 36 (2021): MAC11 Book of Abstracts
Ida Ilyani Adam, Norlaila Mustafa, Norasyikin Abdul Wahab, Nor Akhmar Ibrahim, Pravina Deligannu, HYPOGLYCEMIA ASSESSMENT AMONG TYPE 2 PATIENTS WITH DIABETES RECEIVING INSULIN BASALOG AND INSULIN LANTUS , Journal of the ASEAN Federation of Endocrine Societies: Vol. 34 No. 2 Supplement 1: Book of Abstracts
Mohd Rahman Omar, Norasyikin A Wahab, Norlaila Mustafa, Norlela Sukor, Norazmi Kamaruddin, DOSE UP-TITRATION OF EMPAGLIFLOZIN AMONG TYPE 2 DM PATIENTS UNCONTROLLED ON EXISTING ORAL ANTIDIABETIC AGENTS , Journal of the ASEAN Federation of Endocrine Societies: Vol. 37 No. S2 (2022): MAC12 Book of Abstracts
Darwin Totesora, Ma. Theresa Chua-Agcaoili, Cystic Papillary Thyroid Carcinoma , Journal of the ASEAN Federation of Endocrine Societies: Vol. 34 No. 2 (2019): November Issue


text:
Steve Bannon (PBS)
Frontline's "Bannon's War": An efficient examination of the philosophy steering the White House
Michael Kirk's latest effort for Frontline is a sobering look at what drives Trump adviser Steve Bannon
Check out this article! https://www.salon.com/2017/05/23/frontlines-bannons-war-an-efficient-examination-of-the-philosophy-steering-the-white-house/
May 23, 2017 11:00PM (UTC)
There may be no figure more polarizing, frightening and bewildering than White House chief strategist Steve Bannon, a man who makes George W. Bush's former chief of staff, Karl Rove, seem about as harmful as a zit. If this comparison seems facetious, chalk it up to the aftereffects of watching "Bannon's War," documentarian Michael Kirk's latest effort for "Frontline" that premiers Tuesday at 10 p.m. on PBS member stations and online.
Nothing in this "Frontline" version of Bannon's biography affords a glimpse of humanity or warmth in the man, and perhaps that is for the best. Instead "Bannon's War" shows its subject as the polarizing, intelligent and power-driven figure that he is.
In "Frontline" fashion, it does this without explicitly saying so. Former Breitbart News employees, journalists from The Washington Post, The Boston Globe, The New York Times and The New Yorker, as well as Bannon's former writing partner and ex-friend Julia Jones are among the interviewees who build a case that invites people to come to that conclusion themselves.
That is, assuming the viewer isn't a ticket holder on the Trump Express.
How fairly "Frontline" treats Bannon and whether this Kirk-directed episode is terrifying or validating is matter of perspective. Kirk and his co-writer Michael Wiser tacitly acknowledge this in the cold open before the credits roll by returning to the furor surrounding Donald Trump's signing of the first executive order barring the U.S. entry of travelers from predominately Muslim countries. To those resisting Trump's agenda, the 9th Circuit Court's halt on the executive order was seen as their first victory.
Bannon also viewed this protest spike as proof that "shock and awe" tactics could win, in that it sent a signal to Trump's base that the president wasn't merely spouting xenophobic and racist rhetoric on the campaign trail to get their vote. "Bannon thinks, 'This is great. We're killing it. We're winning. We're doing everything that we said we would,'" former Breitbart spokesman Kurt Bardella says in the film. "'We are beating down the establishment and the liberals into submission. We are literally making America great again.'"
Kirk's list of Frontline projects includes the quadrennial election specials known as "The Choice" as well as the two-night, four-hour miniseries "Divided States of America" that debuted 48 hours before Trump's inauguration.
"Bannon's War" feels frugal in comparison to these efforts, clocking in at just under 55 minutes. But the installment moves with efficient speed as well, spending minimal time chronicling Bannon's early years and affording a relatively slender view of his tenure on Wall Street and in Hollywood, where he built his personal wealth.
Much has been written about Bannon's early obsession with warfare and nationalist foreign policy. Kirk and Wiser's script doesn't dive into this aspect of the man, choosing instead to devote the bulk of the show to illustrating the ways he applied this personal paradigm to shape Breitbart News into a propaganda machine for the far right.
Here is where the "Frontline" episode energizes its premise — as it talks about the bombastic Andrew Breitbart joining forces with "bookish Bannon," showing archival footage of the two cavorting in front of a frat house with Breitbart bragging about past exploits.
Bannon infused the site with funds from wealthy conservatives such as the Mercer family, and after Andrew Breitbart's death Bannon went on to use the site to promote the agenda of Citizens United chairman David Bossie and boost the careers of then-senator Jeff Sessions and Sessions' former communications director Stephen Miller.
But it was only when Donald Trump emerged to run for president that Bannon saw what one interviewee termed as a "vehicle for his perspectives." Those views crystallized in Trump's inauguration speech which, as Jones observes, may have been in the president's hands but was pure Bannon. "The line about carnage in America, I think that was Steve," she says. "Every now and again I hear things and I go, 'OK, that's Steve.'"
"Bannon's War" adheres to the "Frontline" model of lining up recent coverage to recapitulate what we already know in a linear pass. Here the element of what we may not realize may be even more important. By training its focus on the strategy that goes into creating the barrage of frightening headlines, the hour provides a cogent glimpse at Bannon's scorched-earth philosophy.
"There's an almost fetishistic desire to blow everything up," says Washington Post film critic Ann Hornaday, referring to Bannon's post-9/11 Ronald Reagan film "In the Face of Evil," which she also describes as "apocalyptic" and "febrile."
"Bannon's War" is not without its frustrations, but a portion of that can't be helped by Kirk or Wiser. Specifically former Breitbart staffer Bardella and former editor-at-large Ben Shapiro simultaneously lend crucial insight into Bannon's thought process while taking stances that smack of disingenuousness.
Referring to his decision to quit Breitbart News in 2016 as did several other longtime staffers, Shapiro explains, "When a news outlet decides that it is more important to maintain close ties with a particular candidate or politician than it is to maintain the integrity of their journalists, that's no longer a journalistic organization. It is a propaganda platform."
This only makes sense if one views most of what Breitbart did before, including its friendly coverage of certain Republican politicians and lobbying organizations and vilification of minorities and civil rights organizations, as being something other than propaganda.
Nevertheless, Shapiro's and Bardella's insights and others help "Bannon's War" explain why Bannon continues to wield influence in the White House and with Trump's supporters and slice through reports that the chief strategist has fallen out of favor with Trump and could be on his way out of the White House.
Visuals from Trump's journey to and from a rally in Pennsylvania, marking his first 100 days in office, indicate otherwise. "Bannon's War" closes with these images, perhaps doubling as a warning. Alarming though that may be, Kirk's decision to end the hour here signals that this story is far from over. Perversely it may also make a viewer anxious to see which political developments inspire the filmmaker's next sobering work.
Donald Trump Editor's Picks Frontline Partner Video Pbs Steve Bannon Tv
Did Erik Prince commit perjury?
New Mar-a-Lago controversy for Trump
Bad week for truth in mainstream media
Ivanka Trump passes on World Bank job
On parade at West Point 50 years later